Up-regulation of angiotensin II receptors by in vitro differentiation of murine N1E-115 neuroblastoma cells.
In vitro differentiation of murine neuroblastoma N1E-115 cells induced by low serum (0.5%) and dimethyl sulfoxide (1.5%) increased the uptake of 45Ca2+ as well as basal and forskolin-stimulated adenylate cyclase activity. Associated with these biochemical indices of differentiation was an increase in the density of binding sites for the angiotensin II (Ang II) receptor agonist 125I-[Sar1]-Ang II and the antagonist 125I-[Sar1,Ile8]-Ang II (125I-SARILE). This up-regulation was apparent within 24 hr and was maximal at 72 hr. Other manipulations that independently increased intracellular cAMP or Ca2+ levels produced a qualitatively similar up-regulation of Ang II receptors. In vitro differentiation did not diminish the specificity of these receptors for Ang-II related peptides. Sarcosine-substituted Ang II receptor antagonists such as [Sar1,Gly8]-Ang II, [Sar1,Thr8]-Ang II, or SARILE itself competed for 125I-SARILE in a monophasic fashion, whereas the competition displayed by the agonists Ang II, angiotensin III, and Crinia-Ang II for 125I-SARILE-labeled sites was biphasic, consisting of distinct high and low affinity components. Moreover, in vitro differentiation predominantly increased the density of high affinity sites for angiotensin III and Crinia-Ang II, but the lower affinity site for Ang II, and in all three cases the majority of this increased binding was insensitive to guanine nucleotides. Collectively, these results demonstrate that the expression of Ang II receptors on neuron-like cells is regulated by the biochemical events accompanying differentiation and suggest that the biphasic nature of the binding of some angiotensin agonists may be indicative of multiple receptor subtypes.
Reagan
L P
LP
Department of Animal Biology, University of Pennsylvania, Philadelphia 19104.
Ye
X H
XH
Mir
R
R
DePalo
L R
LR
Fluharty
S J
SJ
D000262:Adenylyl Cyclases / Q000032:analysis; D000804:Angiotensin II / Q000378:metabolism*; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002454:Cell Differentiation; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D019204:GTP-Binding Proteins / Q000502:physiology; D006165:Guanylyl Imidodiphosphate / Q000494:pharmacology; D051379:Mice; D009447:Neuroblastoma / Q000737:chemistry / Q000378:metabolism*; D011945:Receptors, Angiotensin / Q000032:analysis* / Q000187:drug effects; D014407:Tumor Cells, Cultured; D015854:Up-Regulation
D011945:Receptors, Angiotensin; D000804:Angiotensin II; D006165:Guanylyl Imidodiphosphate; D019204:GTP-Binding Proteins; D000262:Adenylyl Cyclases; D002118:Calcium; D004121:Dimethyl Sulfoxide